Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Best results found using acetonitrile, water, and trifluoroacetic acid or methanol mixture.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Jamogenin from plants may help hair growth and is a potential alternative to finasteride.

Fluoxetine was not effective in treating hair-pulling disorder in the short term.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

The FDA rejected a testosterone drug again due to safety concerns.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

Finasteride reduces pain in male rats and works better with testosterone.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Melatonin and cortisol affect mink winter hair growth, but β-endorphin levels do not.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Both treatments help hair regrowth, with PRP being slightly better.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.